Bryant Park Capital has a diversified, well-rounded breadth of experience in the Healthcare industry, including telemedicine, population health, and rehab, amongst others.
Healthcare spending in the U.S. exceeds $3 trillion annually and is expected to continue to grow each year. The continued increase in spending is due to a combination of rising prices of medical goods and services (new and expensive treatments), higher spending in Medicare and Medicaid, an aging population, longer life spans, and a greater prevalence of chronic illnesses. Prescription drugs are expected to see the fasted annual growth until 2028, rising an average of 6.3% per year. New screening, detecting, and imaging technologies continue to improve early detection of diseases. New treatments, based on medication, medical devices or medical procedures, are continuing to increase survival rates and quality of life metrics for patients.
BPC offers tailored merger & acquisition and capital raising advisory services to help meet your individual needs. BPC has been a reliable source of market knowledge for clients and is the right choice for companies looking to enter or exit the healthcare business. Our senior investment bankers have been investors and executives in healthcare companies, which allows them to bring a unique understanding of the value proposition, as well as help create opportunities and resolve company specific challenges.